China National Accord Medicines Corporation Ltd. (SHE: 000028)
China
· Delayed Price · Currency is CNY 27.95
-1.26 (-4.31%)
Oct 11, 2024, 3:04 PM CST
China National Accord Medicines Corporation Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,512 | 1,599 | 1,487 | 1,336 | 1,402 | 1,268 | Upgrade
|
| Depreciation & Amortization | 1,474 | 1,390 | 1,307 | 1,242 | 1,035 | 799.66 | Upgrade
|
| Other Amortization | 213.63 | 199.23 | 180.31 | 188.65 | 158.89 | 127.44 | Upgrade
|
| Loss (Gain) From Sale of Assets | -40.66 | -44.67 | -6.26 | -2.7 | -5.57 | -2.34 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.07 | -0.01 | 55.64 | 236.84 | 0.08 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -30.29 | 15.16 | -28.87 | - | - | 1.86 | Upgrade
|
| Provision & Write-off of Bad Debts | 46.73 | 71.36 | 29.77 | 44.22 | 21.23 | 4.77 | Upgrade
|
| Other Operating Activities | 176.93 | 306.59 | 357.4 | 131.94 | 256.33 | 225.93 | Upgrade
|
| Change in Accounts Receivable | -854.96 | -3,992 | 1,227 | -2,121 | -2,990 | -793.31 | Upgrade
|
| Change in Inventory | 101.38 | -170.13 | -217.84 | -1,260 | -406.38 | -511.44 | Upgrade
|
| Change in Accounts Payable | 181.48 | 3,688 | -1,949 | 2,135 | 2,125 | 1,010 | Upgrade
|
| Change in Other Net Operating Assets | -334.52 | -79.9 | 193.22 | -203.6 | -81.3 | -119.94 | Upgrade
|
| Operating Cash Flow | 2,380 | 2,937 | 2,560 | 1,655 | 1,503 | 2,013 | Upgrade
|
| Operating Cash Flow Growth | -20.79% | 14.71% | 54.69% | 10.14% | -25.34% | 52.17% | Upgrade
|
| Capital Expenditures | -306.96 | -322.21 | -322.19 | -370.43 | -293.83 | -251.86 | Upgrade
|
| Sale of Property, Plant & Equipment | 36.17 | 37.88 | 4.94 | 1.02 | 8.57 | 5.31 | Upgrade
|
| Cash Acquisitions | -71.4 | - | -126.35 | -109.95 | -2,646 | -97.8 | Upgrade
|
| Divestitures | -5.78 | -2.55 | - | - | - | 0.79 | Upgrade
|
| Investment in Securities | 6.1 | -3.72 | 89.66 | -144.03 | -31.09 | -56 | Upgrade
|
| Other Investing Activities | 109.63 | 155.16 | 11.12 | 167.86 | 179.21 | 175.25 | Upgrade
|
| Investing Cash Flow | -232.24 | -135.43 | -342.82 | -455.53 | -2,783 | -221.13 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 81.45 | 160.7 | - | Upgrade
|
| Long-Term Debt Issued | - | 1,877 | 1,520 | 932.68 | 857.52 | 286.14 | Upgrade
|
| Total Debt Issued | 2,384 | 1,877 | 1,520 | 1,014 | 1,018 | 286.14 | Upgrade
|
| Short-Term Debt Repaid | - | - | -72.45 | -65.7 | -362.3 | - | Upgrade
|
| Long-Term Debt Repaid | - | -3,061 | -2,629 | -2,100 | -1,700 | -924.72 | Upgrade
|
| Total Debt Repaid | -3,092 | -3,061 | -2,701 | -2,165 | -2,063 | -924.72 | Upgrade
|
| Net Debt Issued (Repaid) | -708.17 | -1,184 | -1,181 | -1,151 | -1,044 | -638.58 | Upgrade
|
| Issuance of Common Stock | 31.6 | 31.6 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -559.22 | -559.07 | -574.19 | -610.54 | -549.91 | -493.06 | Upgrade
|
| Other Financing Activities | -808.96 | -696.11 | 247.65 | -109.86 | -146.1 | 131.42 | Upgrade
|
| Financing Cash Flow | -2,045 | -2,408 | -1,508 | -1,872 | -1,740 | -1,000 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.21 | -0.94 | -1.19 | 0.39 | -0.05 | -0.18 | Upgrade
|
| Net Cash Flow | 102.04 | 393.12 | 708.66 | -671.6 | -3,021 | 791.14 | Upgrade
|
| Free Cash Flow | 2,073 | 2,615 | 2,238 | 1,285 | 1,209 | 1,761 | Upgrade
|
| Free Cash Flow Growth | -22.45% | 16.83% | 74.22% | 6.27% | -31.34% | 65.00% | Upgrade
|
| Free Cash Flow Margin | 2.77% | 3.46% | 3.05% | 1.88% | 2.03% | 3.34% | Upgrade
|
| Free Cash Flow Per Share | 3.73 | 4.70 | 4.02 | 2.31 | 2.17 | 3.16 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 20.14 | 8.12 | Upgrade
|
| Cash Income Tax Paid | 1,873 | 1,887 | 1,782 | 1,564 | 1,498 | 1,278 | Upgrade
|
| Levered Free Cash Flow | 1,378 | 837.24 | 2,410 | 135.8 | -16.63 | 2,869 | Upgrade
|
| Unlevered Free Cash Flow | 1,548 | 992.48 | 2,573 | 315.83 | 144.74 | 3,042 | Upgrade
|
| Change in Net Working Capital | 1,091 | 1,742 | 28.07 | 2,014 | 1,967 | -1,295 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.